Anatomical features of percutaneously closed patent foramen ovale in patients with cryptogenic stroke

Maikel H M Immens1, Lars S Witte2, Abdelhak El Bouziani2

  • 1Department of Neurology, Radboudumc, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.

Abstract

Insights

Patent foramen ovale (PFO) closure is common for cryptogenic stroke, but 20% of patients lacked typical risk factors. Individual assessment by a Heart-Stroke Team is crucial for PFO-related stroke management.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Diagnostics

Background:

  • Patent foramen ovale (PFO) is a common condition, found in ~25% of the general population.
  • PFO is increasingly recognized as a cause of cryptogenic stroke, particularly in younger individuals.
  • Identifying PFO as the cause of stroke is crucial for appropriate patient management.

Purpose of the Study:

  • To examine the anatomical characteristics of PFOs in patients who underwent percutaneous PFO closure for cryptogenic stroke.
  • To assess the prevalence of risk-enhancing PFO features in patients undergoing closure.
  • To evaluate the role of interdisciplinary Heart-Stroke Teams (HST) in patient selection.

Main Methods:

  • Retrospective data collection of patients undergoing PFO closure between 2016 and 2022.
  • Transesophageal echocardiography was used to measure PFO anatomical characteristics.
  • Analysis performed by two experienced cardiologists.

Main Results:

  • 223 patients underwent PFO closure, with a mean age of 42.8 years.
  • Over 80% of patients exhibited at least one risk-enhancing PFO feature (moderate-to-severe shunt and/or atrial septal aneurysm >10 mm).
  • Despite HST assessment, 20% of closed PFOs lacked these specific risk-enhancing features.

Conclusions:

  • Individualized assessment by a Heart-Stroke Team is vital for managing young stroke patients with PFO.
  • A significant proportion of patients undergoing PFO closure may not present with all typical risk-enhancing features.
  • Further research is needed to elucidate stroke mechanisms in PFO patients without clear risk factors.

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...